2025Frost & Sullivan Healthcare Blue Book Annual Summary

Driven by technological breakthroughs, policy guidance, and market demand, the global healthcare industry is undergoing a profound and extensive transformation. From the global exploration of rare disease treatments and biopharmaceutical innovations, to the deep integration of AI technology and life sciences, and then to the iterative upgrading of high-end medical devices, each sub-field harbors tremendous opportunities and challenges.

As a global growth consulting firm, Frost & Sullivan (Frost & Sullivan, abbreviated as 'Frost & Sullivan') continues to delve into the healthcare sector, dedicated to providing reliable references for sustainable growth through objective facts-based industry analysis, in-depth insights into trends, and forward-looking judgment. The Frost & Sullivan Blue Book, with its independent and rigorous perspective, closely follows the pulse of the industry, focuses on growth tracks, and systematically sorts out the development context and future direction of the industry. With its professional insights and industry credibility, the Blue Book further integrates multiple values such as education, branding, and resources on the basis of clarifying the current industry situation: by rallying consensus and facing challenges head-on, it promotes positive industry voices and cognitive improvement; by leveraging global media and international ecological resources, it strengthens the core advantages of cooperative enterprises and their global market presence; at the same time, with precise resource linkages as a bond, it introduces the attention and opportunities required for development to enterprises.

Overview (partial) of the released Blue Book on Healthcare 2025

How Does the Frost & Sullivan Blue Book Empower Enterprises?

While bringing in-depth industry insights to partners, Frost & Sullivan Blue Book also constructs an all-round value-empowering system:

1. Industrial education

The maturity and development of an industry require positive, precise, and continuous advocacy. The Blue Book can leverage Frost & Sullivan's professional analytical capabilities, its strong capital market brand, and the deep involvement of sponsors to identify the pain points that the industry urgently needs to address. Ultimately, it serves to positively educate and invest in the market, as well as resonate with and provoke thought within the industry.

2. Highlight the company's brand value and enhance its industry influence

The Blue Book will be published simultaneously on Frost & Sullivan's own media, vertical media, and major first- and second-tier financial media platforms, attracting a wide range of readers. The Blue Book will fully showcase the company's products, technologies, and differentiated competitive advantages, enhance the company's exposure in the capital market, and increase its visibility and influence.

3. The Blue Book helps Chinese biotech companies promote their global brands and implement international business operations

The global distribution network of Frost & Sullivan's Blue Book covers top domestic and international media platforms, reaching hundreds of millions of customers. It integrates multiple communication channels such as media, funds, banks, and securities firms. With over 5,000 high-quality media resources, it can efficiently deploy precise promotion strategies.

Relying on the globalization brand expertise and cross-market influence of Frost & Sullivan, the Blue Book can not only continuously stimulate domestic and international attention to related industries but also strongly support enterprises in highlighting their core advantages and differentiated competitiveness. With its extensive business layout in developed and emerging markets, Frost & Sullivan not only provides industry insights with an international perspective but also offers systematic support for partners to expand overseas opportunities and enhance their international influence through the deep linkage of the global capital network.

Overview (partial) of the released Blue Books on Healthcare over the Years

Access to Past Years' Healthcare Reports from Frost & Sullivan (Partial)

For more cooperation and consultation on healthcare blue books,